Schrödinger Q2 revenue $54.8M (+16% YoY); narrows net loss; maintains revenue guidance, lowers expense guidance

Schrodinger, Inc.

2025-Q2 EPS reported -$1.41 revenue$114,310,000

Total revenue $54.8M (+16% YoY); software revenue $40.5M (+15%); drug discovery $14.2M (+19%).
Net loss improved to $43.2M from $54.0M; non-GAAP net loss $47.5M.
Guidance: Software revenue growth 10-15% reaffirmed; op. expenses expected lower than 2024; cash burn significantly lower.
SGR-1505 FDA Fast Track; initial Phase 1 data presented; exploring strategic options; SGR-2921/SGR-3515 data Q4 2025.
May 7% workforce reduction expected to save ~$30M annually; new CFO Richie Jain appointed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.